Format

Send to

Choose Destination
Am J Physiol Lung Cell Mol Physiol. 2013 Mar 1;304(5):L307-11. doi: 10.1152/ajplung.00378.2012. Epub 2012 Dec 21.

The role of autoimmunity in obliterative bronchiolitis after lung transplantation.

Author information

1
Center for Immunobiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Abstract

First performed in the 1960s with long-term successes achieved in the 1980s, lung transplantation remains the only definitive treatment option for end-stage lung disease. Chronic lung rejection, pathologically classified as obliterative bronchiolitis (OB) with its clinical correlate referred to as bronchiolitis obliterans syndrome, is the limiting factor than keeps 5-yr survival rates for lung transplant significantly worse than for other solid organ transplants. Initially, OB was largely attributed to immune responses to donor antigens, alloimmunity. However, more recent work has demonstrated the role of autoimmunity in the process of lung transplant rejection. IL-17 and autoantigens such as collagen type V and K-α1 tubulin have been implicated in the development of chronic rejection. Ultimately, this translational review discusses the role that autoimmunity plays in the development of OB and lung transplant rejection and then discusses options for therapeutic intervention.

PMID:
23262227
PMCID:
PMC3602736
DOI:
10.1152/ajplung.00378.2012
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center